| (pro) renin receptor knockdown attenuates liver fibrosis through inactivation of ERK/TGF-? 1/Smad3 pathway YC Hsieh, KC Lee, KH Lan, TI Huo, YH Huang, MC Hou, HC Lin Journal of Hepatology 73, S527-S528, 2020 | | 2020 |
| (Pro) renin receptor knockdown attenuates liver fibrosis through inactivation of ERK/TGF-β1/SMAD3 pathway YC Hsieh, KC Lee, HJ Lei, KH Lan, TI Huo, YT Lin, CC Chan, B Schnabl, ... Cellular and Molecular Gastroenterology and Hepatology 12 (3), 813-838, 2021 | 17 | 2021 |
| 2'‐Hydroxyflavanone ameliorates mesenteric angiogenesis and portal‐systemic collaterals in rats with liver fibrosis IF Hsin, JY Lee, TI Huo, FY Lee, HC Huang, SJ Hsu, SS Wang, HL Ho, ... Journal of gastroenterology and hepatology 31 (5), 1045-1051, 2016 | 11 | 2016 |
| 3‐Mercaptopyruvate sulfurtransferase in hepatocellular carcinoma: Is it an authentic clinical prognostic predictor? TI Huo, JI Liao, SY Ho Liver International 42 (6), 2022 | 2 | 2022 |
| 468 DATA MINING MODEL FOR IDENTIFICATION OF PATIENTS AT HIGH RISK FOR HEPATOCELLULAR CARCINOMA AFTER ERADICATION OF HEPATITIS C M Kurosaki, N Izumi Journal of Hepatology, S192, 2013 | 1 | 2013 |
| 618 EFFECTS OF DIABETES AND BLOOD GLUCOSE MODULATION ON THE INTRAHEPATIC VASCULAR RESPONSE TO ENDOTHELIN-1 IN CIRRHOTIC RATS JY Lee, TI Huo, HC Huang, FY Lee Journal of Hepatology, S252, 2013 | | 2013 |
| 658 HEPATIC RESECTION CAN PROVIDE LONG-TERM SURVIVAL OF PATIENTS IN BARCELONA CLINICAL LIVER CANCER STAGE B OR C HEPATOCELLULAR CARCINOMA CW Su, GY Chau, CY Hsia, JC Wu, TI Huo, YH Huang, HC Lin, WY Lui, ... Journal of Hepatology, S265-S266, 2011 | | 2011 |
| 833 DIFFERENTIAL ROLES OF TUMOR, HEPATIC INFLAMMATION AND HEPATITIS B VIRUS IN EARLY AND LATE HEPATOCELLULAR CARCINOMA RECURRENCES JC Wu, YH Huang, GY Chau, CW Su, CR Lai, PC Lee, TI Huo, IJ Sheen Journal of Hepatology, S304, 2009 | | 2009 |
| A commentary on ‘development and validation of safety and efficacy-associated risk calculator for hepatocellular carcinoma in the elderly after resection (searcher): a multi … TI Huo, SY Ho, JI Liao International Journal of Surgery 109 (2), 204-205, 2023 | | 2023 |
| A commentary on ‘Nomograms for predicting the recurrence probability and recurrence-free survival in patients with hepatocellular carcinoma after conversion hepatectomy based … TI Huo, SY Ho, JI Liao International Journal of Surgery 109 (8), 2529-2530, 2023 | | 2023 |
| A commentary on “Prothrombin induced by vitamin K Absence-II versus alpha-fetoprotein in detection of both resectable hepatocellular carcinoma and early recurrence after … TI Huo, SY Ho, JI Liao International Journal of Surgery 106, 106910, 2022 | | 2022 |
| A comparison of clinical manifestations and prognoses between patients with hepatocellular carcinoma and Child–Pugh scores of 5 or 6 HH Hung, Y Chao, YY Chiou, CP Li, RC Lee, TI Huo, YH Huang, ... Medicine 93 (29), e348, 2014 | 21 | 2014 |
| A comparison of prognoses between surgical resection and radiofrequency ablation therapy for patients with hepatocellular carcinoma and esophagogastric varices CY Wei, GY Chau, PH Chen, CA Liu, YH Huang, TI Huo, MC Hou, HC Lin, ... Scientific reports 10 (1), 17259, 2020 | 12 | 2020 |
| A comparison of surgical resection and transarterial chemoembolization for solitary hepatocellular carcinoma larger than 10 cm: A propensity score matching analysis HS Lu, CW Su, WY Kao, TI Huo, YH Huang, MC Hou, HC Lin, JC Wu Journal of Hepatology 68, S211, 2018 | | 2018 |
| A new ALBI‐based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma IC Lee, YW Hung, CA Liu, RC Lee, CW Su, TI Huo, CP Li, Y Chao, HC Lin, ... Liver International 39 (9), 1704-1712, 2019 | 71 | 2019 |
| A new Child-Turcotte-Pugh class 0 for patients with hepatocellular carcinoma: determinants, prognostic impact and ability to improve the current staging systems YH Lee, CY Hsu, CW Chu, PH Liu, CY Hsia, YH Huang, CW Su, YY Chiou, ... PloS one 9 (6), e99115, 2014 | 13 | 2014 |
| A new prognostic model based on albumin–bilirubin grade for hepatocellular carcinoma beyond the Milan criteria SY Ho, PH Liu, CY Hsu, CY Hsia, YH Huang, CW Su, HJ Lei, RC Lee, ... Digestive Diseases and Sciences 65, 658-667, 2020 | 15 | 2020 |
| A new prognostic model for hepatocellular carcinoma based on total tumor volume: the Taipei Integrated Scoring System CY Hsu, YH Huang, CY Hsia, CW Su, HC Lin, CC Loong, YY Chiou, ... Journal of hepatology 53 (1), 108-117, 2010 | 193 | 2010 |
| A new treatment-integrated prognostic nomogram of the barcelona clinic liver cancer system for hepatocellular carcinoma CY Hsu, PH Liu, CY Hsia, YH Lee, TS Nagaria, RC Lee, SY Ho, MC Hou, ... Scientific reports 7 (1), 7914, 2017 | 7 | 2017 |
| A new tumor burden score and albumin–bilirubin grade-based prognostic model for hepatocellular carcinoma SY Ho, PH Liu, CY Hsu, YH Huang, JI Liao, CW Su, MC Hou, TI Huo Cancers 14 (3), 649, 2022 | 21 | 2022 |
Shou-Dong LeeCheng Hsin General Hospital, Taipei, Taiwan在 vghtpe.gov.tw 的电子邮件经过验证
